Articles

Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma

University of Texas Southwestern Medical Center, Dallas, TX
Baylor Scott & White Health, Temple, TX
University of Texas Southwestern Medical Center, Dallas, TX
Yale University School of Medicine, New Haven, CT
The University of Texas MD Anderson Cancer Center, Houston, TX
Angimmune, LLC, Bethesda, MD, USA
Angimmune, LLC, Bethesda, MD, USA
Vol. 100 No. 6 (2015): June, 2015 https://doi.org/10.3324/haematol.2015.123711